SCHEMBL6058747

SCHEMBL6058747

CCOC(=O)C1CCN(c2ccc(N3C[C@H](CNC(C)=O)OC3=O)cc2F)CC1

nearest known ligand 0.71

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.71
MAOB P27338 4/20 0.71
PTGS1 P23219 2/20 0.71
SDHA P31040 2/20 0.71
LMNA P02545 1/20 0.71
CALML3 P27482 1/20 0.71
F10 P00742 6/20 0.58
ITGB3 P05106 3/20 0.58
PRSS1 P07477 3/20 0.58
PRSS2 P07478 3/20 0.58
ITGA2B P08514 3/20 0.58
PRSS3 P35030 3/20 0.58
TOP2B Q02880 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6058753 1.00 MAOA (0.71) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6992074 0.89 MAOB (0.79) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6992080 0.89 MAOB (0.79) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6994115 0.88 MAOB (0.78) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6996682 0.88 MAOB (0.78) MAOAMAOBPTGS1SDHALMNA
SCHEMBL14612500 0.88 MAOB (0.74) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6991510 0.88 MAOB (0.76) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6991516 0.88 MAOB (0.76) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6993651 0.87 MAOB (0.75) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6993645 0.87 MAOB (0.75) MAOAMAOBPTGS1SDHALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0750618-B1 OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM UPJOHN CO (US) 2003-02-19 EP claimed
JP-8073455-A None JP disclosed
EP-1212058-B1 TOPICAL TREATMENT FOR PREVENTION OF OCULAR INFECTIONS INSITE VISION INC (US) 2006-08-23 EP disclosed
EP-0750618-B1 OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM UPJOHN CO (US) 2003-02-19 EP disclosed
US-6441188-B1 SUCH AS (S)-N-((3-(3-FLUORO-4-(1,1-DIOXOTHIAZOLIDIN-3-YL) PHENYL)-2-OXO-5-OXAZOLIDINYL)METHYL)ACETAMIDE N-OXIDE FOR TREATMENT OF MICROBIAL INFECTIONS PHARMACIA & UPJOHN COMPANY 2002-08-27 US disclosed
EP-1212058-A1 TOPICAL TREATMENT FOR PREVENTION OF OCULAR INFECTIONS INSITE VISION INCORPORATED (US) 2002-06-12 EP disclosed
WO-2001019366-A1 TOPICAL TREATMENT FOR PREVENTION OF OCULAR INFECTIONS INSITE VISION INCORPORATED (US) 2001-03-22 WO disclosed
EP-1019385-A1 AMINOARYL OXAZOLIDINONE N-OXIDES PHARMACIA & UPJOHN COMPANY (US) 2000-07-19 EP disclosed
US-5668286-A ANTIBIOTIC PHARMACIA & UPJOHN COMPANY (US) 1997-09-16 US disclosed
WO-1997010223-A1 AMINOARYL OXAZOLIDINONE N-OXIDES PHARMACIA & UPJOHN COMPANY (US) 1997-03-20 WO disclosed
EP-0754175-A1 ALKOXY-ALKYL-SUBSTITUTED 1-H-3-ARYL-PYRROLIDINE-2,4-DIONES USED AS HERBICIDES AND PESTICIDES BAYER AG (DE) 1997-01-22 EP disclosed
JP-H0873455-A OXAZOLIDINONE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE SAME AS ACTIVE COMPONENT UPJOHN CO:THE 1996-03-19 JP disclosed